Search

01/03/2025 INITIATING GLUCOSE MONITORING IN PERSONS WITH TYPE 2 DIABETES MELLITUS. A RANDOMIZED CONTROL TRIAL COMPARING FSL2 VS. CAPILLARY BLOOD GLUCOSE IN TERMS OF TREATMENT SATISFACTION
Mangas, N, Abraldes, N, Martínez, MJ, Figueroa, D, Ramos, M, López, A, Martínez, C, Pujol, I, Mauricio, D, Corcoy, R. INITIATING GLUCOSE MONITORING IN PERSONS WITH TYPE 2 DIABETES MELLITUS. A RANDOMIZED CONTROL TRIAL COMPARING FSL2 VS. CAPILLARY BLOOD GLUCOSE IN TERMS OF TREATMENT SATISFACTION. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025 NON-INVASIVE NEAR-INFRARED SYSTEM FOR SCREENING FOR DIABETES: THE RESULTS FROM ANODE03
Paldánius, PM, Cos, X, Lazaro-Pancheco, D, Salter, J, Mauricio, D. NON-INVASIVE NEAR-INFRARED SYSTEM FOR SCREENING FOR DIABETES: THE RESULTS FROM ANODE03. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025 ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS
Paldánius, PM, Salter, J, Hernandez, ME, Tipo, B, Franch, J, Cos, X, Mauricio, D. ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025 BENEFIT:RISK ASSESSMENT OF A NOVEL NON-INVASIVE SCREENING TOOL: INSIGHTS FROM THE ANODE CLINICAL PROGRAMME
Paldánius, PM, Salter, J, Choudhary, P, Cos, X, Mauricio, D. BENEFIT:RISK ASSESSMENT OF A NOVEL NON-INVASIVE SCREENING TOOL: INSIGHTS FROM THE ANODE CLINICAL PROGRAMME. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025 USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY
Chico, A, Ampudia-Blasco, FJ, Daín, A, Scheibner, K, Dagenbach, N, Grifoll-Romero, L, Barmaymon, D, Vogt, G, Best, J, Etter, T. USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/02/2022 Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas
Tritos NA, Fazeli PK, McCormack A, Mallea-Gil SM, Pineyro MM, Christ-Crain M, Frara S, Labadzhyan A, Ioachimescu AG, Shimon I, Takahashi Y, Gurnell M, Fleseriu M, Valassi E., Wierman, Margaret E.. Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas. Pituitary. 2022; 25(1)DOI:10.1007/s11102-021-01170-3. PMID:34283370. IF:3.800(Q2/5D).
01/09/2021 Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis.
Calderon-Mediavilla M, Vila-Badia R, Dolz M, Butjosa A, Barajas A, Del Cacho N, Sánchez B, Pardo M, Baños I, Usall J, Ochoa S, Santos, A, Nunez, C, Soler, A.. Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis.. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2021; 30(9)DOI:10.1007/s00787-020-01618-0. PMID:32865655. IF:5.349(Q1/1D).
01/02/2026 Oxytocin levels do not change around a meal and correlate with reward-driven caloric consumption in adults with obesity
Wronski, M, Boutin, R, Sailer, CO, Galbiati, F, Aulinas, A, Muhammed, M, Eddy, KT, Thomas, JJ, Kerem, L, Carter, CS, Nazarloo, S, Davis, JM, Blevins, JE, Holman, K, Gydus, J, Smith, SE, Asanza, E, Plessow, F, Lawson, EA. Oxytocin levels do not change around a meal and correlate with reward-driven caloric consumption in adults with obesity. DIABETES OBESITY & METABOLISM. 2026; 28(2)DOI:10.1111/dom.70340. PMID:41392857. IF:5.700(Q1/2D).